Can a third Covid-19 vaccination protect people with weakened immune systems?

A new clinical trial led by the Universities of Birmingham and Glasgow has launched in the UK to determine whether a third dose of vaccine will improve the immune response for people who have weakened immune systems. The study, OCTAVE DUO, will offer people who are immunosuppressed or immunocompromised a Pfizer, Moderna or Novavax vaccine … Continue reading “Can a third Covid-19 vaccination protect people with weakened immune systems?”

Global COVID-19 surgery study scoops scientific world record

A study led by experts at BHP founder-member the University of Birmingham has been awarded the Guinness World Records title for the world’s largest scientific collaboration – involving over 140,000 patients in 116 countries. The record for ‘Most authors on a single peer-reviewed academic paper’ is now held by the Universities of Birmingham and Edinburgh after … Continue reading “Global COVID-19 surgery study scoops scientific world record”

AI to improve treatments for people with multiple long-term conditions

The NIHR has awarded £2.5 million for new artificial intelligence (AI) research led by the University of Birmingham. The study will use AI to produce computer programmes and tools to help doctors improve the choice of drugs for patients with clusters of multiple long-term conditions. Called the OPTIMAL study (OPTIMising therapies, discovering therapeutic targets and … Continue reading “AI to improve treatments for people with multiple long-term conditions”

Research explores impact on informal, home-based Covid-19 carers

Informal carers in the Midlands who looked after people that died from a terminal illness at home during the COVID-19 pandemic are being asked to take part in a research project funded by Marie Curie and led by BHP founder member the University of Birmingham. Marie Curie, which supports over 1,300 patients in the West … Continue reading “Research explores impact on informal, home-based Covid-19 carers”

AI identifies patients with heart failure that respond to beta-blocker treatment

Researchers at BHP founder-member the University of Birmingham have developed a new way to identify which patients with heart failure will benefit from treatment with beta-blockers. Heart failure is one of the most common heart conditions, with substantial impact on patient quality of life, and a major driver of hospital admissions and healthcare cost. The … Continue reading “AI identifies patients with heart failure that respond to beta-blocker treatment”